Phase III Trial Bodes Well for Investigational Treatment for Vasculitis Treatment Sending ChemoCentryx Shares up 250%
The ADVOCATE trial, sponsored by ChemoCentryx, assessed the safety of CCX168(avacopan) in inducing and sustaining remission in patients with anti-neutrophil […]
